NCT04527419View on ClinicalTrials.gov

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)

NARecruitingINTERVENTIONAL
Enrollment

545

Participants

Timeline

Start Date

February 9, 2022

Primary Completion Date

July 21, 2026

Study Completion Date

February 9, 2027

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
PROCEDURE

No mediastinal lymph node dissection

No mediastinal lymph node dissection will be performed.

Trial Locations (1)

Unknown

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER